Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVEAL 475 System and Bevonescein for Nerve Visualization in Head and Neck Surgery
NCT06227585Phase 3Completed
- Sponsor
- Alume Biosciences
- Start
- Nov 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of bevonescein in head and neck surgery, sponsored by Alume Biosciences. Started Nov 2023; status: completed.
02
Drugs
bevonescein
03
Conditions
head and neck surgery
Beyond the preview
Go deeper on NCT06227585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06227585.